Aptus Capital Advisors »

iShares Dow Jones US Pharm Indx shares owned by Aptus Capital Advisors

Quarter-by-quarter ownership of iShares Dow Jones US Pharm Indx (IHE) shares owned by Aptus Capital Advisors from 13F filings

Historical chart of Aptus Capital Advisors investment in iShares Dow Jones US Pharm Indx

Tip: Access up to 7 years of quarterly data

All positions including iShares Dow Jones US Pharm Indx held by Aptus Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares Dow Jones US Pharm Indx by Aptus Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.1k 86 70.60
2024-06-30 $12M 183k 66.32

More positions owned by Aptus Capital Advisors

Etf Ser Solutions Aptus Collrd Inv (ACIO)
Etf Ser Solutions Aptus Defined (DRSK)
Broadcom (AVGO)
Apple (AAPL)
Etf Ser Solutions Opus Sml Cp Vl (OSCV)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Etf Ser Solutions Aptus Enhanced (JUCY)
Ishares Tr Core Msci Intl (IDEV)
Etf Ser Solutions Aptus Int Enh Yl (IDUB)
Etf Ser Solutions Aptus Large Cap (DUBS)
Invesco Exch Trd Slf Idx Bulshs 2026 Cb (BSCQ)
Etf Ser Solutions Aptus Drawdown (ADME)
Amazon (AMZN)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Aptus Capital Advisors

Top funds holding iShares Dow Jones US Pharm Indx

Fisher Investments
Morgan Stanley
Rockport Wealth
Bank of America Corporation
Brown Advisory Holdings Incorporated
LPL Financial
Royal Bank of Canada
Wells Fargo & Company
Susquehanna International
Raymond James & Associates
Peapack Gladstone Financial Corp
Southern Capital Advisors
Commonwealth Equity Services
Thrivent Financial for Lutherans
Merit Financial Group

View all funds holding iShares Dow Jones US Pharm Indx